• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺激素通路基因多态性与健康受试者的血浆促甲状腺激素及碘甲状腺原氨酸水平相关。

Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects.

作者信息

Peeters Robin P, van Toor Hans, Klootwijk Willem, de Rijke Yolanda B, Kuiper George G J M, Uitterlinden Andre G, Visser Theo J

机构信息

Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, 3000 DR The Netherlands.

出版信息

J Clin Endocrinol Metab. 2003 Jun;88(6):2880-8. doi: 10.1210/jc.2002-021592.

DOI:10.1210/jc.2002-021592
PMID:12788902
Abstract

Single nucleotide polymorphisms (SNPs) in genes involved in thyroid hormone metabolism may affect thyroid hormone bioactivity. We investigated the occurrence and possible effects of SNPs in the deiodinases (D1-D3), the TSH receptor (TSHR), and the T(3) receptor beta (TR beta) genes. SNPs were identified in public databases or by sequencing of genomic DNA from 15 randomly selected subjects (30 alleles). Genotypes for the identified SNPs were determined in 156 healthy blood donors and related to plasma T(4), free T(4), T(3), rT(3), and TSH levels. Eight SNPs of interest were identified, four of which had not yet been published. Three are located in the 3'-untranslated region: D1a-C/T (allele frequencies, C = 66%, T = 34%), D1b-A/G (A = 89.7%, G = 10.3%), and D3-T/G (T = 85.5%, G = 14.2%). Four are missense SNPs: D2-A/G (Thr92Ala, Thr = 61.2%, Ala = 38.8%), TSHRa-G/C (Asp36His, Asp = 99.4%, His = 0.6%), TSHRb-C/A (Pro52Thr, Pro = 94.2%, Thr = 5.8%), and TSHRc-C/G (Asp727Glu, Asp = 90.7%, Glu = 9.3%). One is a silent SNP: TR beta-T/C (T = 96.8%, C = 3.2%). D1a-T was associated in a dose-dependent manner with a higher plasma rT(3) [CC, 0.29 +/- 0.01; CT, 0.32 +/- 0.01; and TT, 0.34 +/- 0.02 nmol/liter (mean +/- SE); P = 0.017], a higher plasma rT(3)/T(4) (P = 0.01), and a lower T(3)/rT(3) (P = 0.003) ratio. The D1b-G allele was associated with lower plasma rT(3)/T(4) (P = 0.024) and with higher T(3)/rT(3) (P = 0.08) ratios. TSHRc-G was associated with a lower plasma TSH (CC, 1.38 +/- 0.07, vs. GC, 1.06 +/- 0.14 mU/liter; P = 0.04), and with lower plasma TSH/free T(4) (P = 0.06), TSH/T(3) (P = 0.06), and TSH/T(4) (P = 0.08) ratios. No associations with TSH and iodothyronine levels were found for the other SNPs. We have analyzed eight SNPs in five thyroid hormone pathway genes and found significant associations of three SNPs in two genes (D1, TSHR) with plasma TSH or iodothyronine levels in a normal population.

摘要

参与甲状腺激素代谢的基因中的单核苷酸多态性(SNP)可能会影响甲状腺激素的生物活性。我们研究了脱碘酶(D1 - D3)、促甲状腺激素受体(TSHR)和T(3)受体β(TRβ)基因中SNP的发生情况及其可能的影响。通过公共数据库或对15名随机选择的受试者(30个等位基因)的基因组DNA进行测序来鉴定SNP。在156名健康献血者中确定了所鉴定SNP的基因型,并将其与血浆T(4)、游离T(4)、T(3)、反T(3)和TSH水平相关联。鉴定出8个感兴趣的SNP,其中4个尚未发表。3个位于3'-非翻译区:D1a - C/T(等位基因频率,C = 66%,T = 34%)、D1b - A/G(A = 89.7%,G = 10.3%)和D3 - T/G(T = 85.5%,G = 14.2%)。4个是错义SNP:D2 - A/G(Thr92Ala,Thr = 61.2%,Ala = 38.8%)、TSHRa - G/C(Asp36His,Asp = 99.4%,His = 0.6%)、TSHRb - C/A(Pro52Thr,Pro = 94.2%,Thr = 5.8%)和TSHRc - C/G(Asp727Glu,Asp = 90.7%,Glu = 9.3%)。1个是沉默SNP:TRβ - T/C(T = 96.8%,C = 3.2%)。D1a - T与较高的血浆反T(3)呈剂量依赖性相关[CC,0.29±0.01;CT,0.32±0.01;TT,0.34±0.02 nmol/升(平均值±标准误);P = 0.017],较高的血浆反T(3)/T(4)(P = 0.01),以及较低的T(3)/反T(3)(P = 0.003)比值。D1b - G等位基因与较低的血浆反T(3)/T(4)(P = 0.024)和较高的T(3)/反T(3)(P = 0.08)比值相关。TSHRc - G与较低的血浆TSH相关(CC,1.38±0.07,vs. GC,1.06±0.14 mU/升;P = 0.04),以及较低的血浆TSH/游离T(4)(P = 0.06)、TSH/T(3)(P = 0.06)和TSH/T(4)(P = 0.08)比值。其他SNP与TSH和碘甲状腺原氨酸水平未发现关联。我们分析了5个甲状腺激素途径基因中的8个SNP,发现在正常人群中,2个基因(Dl、TSHR)中的3个SNP与血浆TSH或碘甲状腺原氨酸水平存在显著关联。

相似文献

1
Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects.甲状腺激素通路基因多态性与健康受试者的血浆促甲状腺激素及碘甲状腺原氨酸水平相关。
J Clin Endocrinol Metab. 2003 Jun;88(6):2880-8. doi: 10.1210/jc.2002-021592.
2
Associations between single nucleotide polymorphisms in thyroid hormone transporter genes (MCT8, MCT10 and OATP1C1) and circulating thyroid hormones.甲状腺激素转运蛋白基因(MCT8、MCT10 和 OATP1C1)单核苷酸多态性与循环甲状腺激素的关系。
Clin Chim Acta. 2013 Oct 21;425:227-32. doi: 10.1016/j.cca.2013.08.017. Epub 2013 Aug 24.
3
Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients.危重症患者组织中甲状腺激素的激活减少和失活增加。
J Clin Endocrinol Metab. 2003 Jul;88(7):3202-11. doi: 10.1210/jc.2002-022013.
4
Identification and consequences of polymorphisms in the thyroid hormone receptor alpha and beta genes.甲状腺激素受体α和β基因多态性的鉴定及其后果。
Thyroid. 2008 Oct;18(10):1087-94. doi: 10.1089/thy.2008.0236.
5
The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe.1型和2型脱碘酶基因多态性与循环甲状腺激素参数及内侧颞叶萎缩的关联。
J Clin Endocrinol Metab. 2007 Feb;92(2):636-40. doi: 10.1210/jc.2006-1331. Epub 2006 Nov 14.
6
A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans.I型脱碘酶的一种多态性与人类循环游离胰岛素样生长因子I水平及身体组成有关。
J Clin Endocrinol Metab. 2005 Jan;90(1):256-63. doi: 10.1210/jc.2004-1301. Epub 2004 Oct 13.
7
A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters.II型脱碘酶基因中的一种新的多态性与循环甲状腺激素参数相关。
Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E75-81. doi: 10.1152/ajpendo.00571.2004. Epub 2005 Feb 22.
8
Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma.分化型甲状腺癌治愈患者血清促甲状腺激素水平与骨转换指标之间的甲状腺激素非依赖性关联。
Eur J Endocrinol. 2008 Jul;159(1):69-76. doi: 10.1530/EJE-08-0038. Epub 2008 Apr 7.
9
Correlation between the TSHRc-Asp727Glu polymorphism and plasma thyroid stimulating hormone levels in Romanian preeclamptic women.罗马尼亚先兆子痫妇女 TSHRc-Asp727Glu 多态性与血浆促甲状腺激素水平的相关性。
Gynecol Endocrinol. 2011 Apr;27(4):225-31. doi: 10.3109/09513590.2010.526658. Epub 2010 Nov 30.
10
The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma.2 型脱碘酶 ORFa-Gly3Asp 多态性(rs12885300)影响分化型甲状腺癌患者下丘脑-垂体-甲状腺轴的设定点。
J Clin Endocrinol Metab. 2011 Sep;96(9):E1527-33. doi: 10.1210/jc.2011-0235. Epub 2011 Jun 29.

引用本文的文献

1
Clinical thyroidology: beyond the 1970s' TSH-T4 Paradigm.临床甲状腺学:超越20世纪70年代的促甲状腺激素-甲状腺素范式
Front Endocrinol (Lausanne). 2025 Jun 24;16:1529791. doi: 10.3389/fendo.2025.1529791. eCollection 2025.
2
Treatment of hypothyroidism with levothyroxine plus slow-release liothyronine: a study protocol for a randomized controlled double-blinded clinical trial.左甲状腺素联合缓释碘塞罗宁治疗甲状腺功能减退症:一项随机对照双盲临床试验的研究方案
Trials. 2025 Jul 1;26(1):228. doi: 10.1186/s13063-025-08940-5.
3
Pregnancy-associated thyroid disorders: the role of genetic, epigenetic, and oxidative stress factors.
妊娠相关甲状腺疾病:遗传、表观遗传和氧化应激因素的作用
Rev Endocr Metab Disord. 2025 Jun 9. doi: 10.1007/s11154-025-09974-5.
4
Brain Abnormalities in Young Single- and Double-Heterozygote Mice for Both Nkx2-1- and Pax8-Null Mutations.Nkx2-1和Pax8基因敲除突变的年轻单杂合子和双杂合子小鼠的脑异常
Mol Neurobiol. 2025 Apr;62(4):4023-4041. doi: 10.1007/s12035-024-04524-7. Epub 2024 Oct 8.
5
Three candidate SNPs show associations with thyroid-stimulating hormone in euthyroid subjects: Tehran thyroid study.三个候选单核苷酸多态性与甲状腺功能正常受试者的促甲状腺激素存在关联:德黑兰甲状腺研究。
J Diabetes Metab Disord. 2024 Jan 23;23(1):1047-1055. doi: 10.1007/s40200-023-01383-2. eCollection 2024 Jun.
6
Gene polymorphisms and thyroid hormone signaling: implication for the treatment of hypothyroidism.基因多态性与甲状腺激素信号转导:对甲状腺功能减退症治疗的启示。
Endocrine. 2024 May;84(2):309-319. doi: 10.1007/s12020-023-03528-y. Epub 2023 Sep 23.
7
Association between DIO2 Thr92Ala polymorphism and hypertension in patients with hypothyroidism: Korean Genome and Epidemiology Study.DIO2 Thr92Ala 多态性与甲状腺功能减退症患者高血压的相关性:韩国基因组与流行病学研究。
Korean J Intern Med. 2023 Mar;38(2):226-237. doi: 10.3904/kjim.2022.292. Epub 2023 Jan 17.
8
TSH-β gene polymorphism in Saudi patients with thyroid cancer: A case-control study.沙特甲状腺癌患者的促甲状腺激素β基因多态性:一项病例对照研究。
Saudi Pharm J. 2022 Nov;30(11):1538-1542. doi: 10.1016/j.jsps.2022.07.015. Epub 2022 Jul 29.
9
From hormone replacement therapy to regenerative scaffolds: A review of current and novel primary hypothyroidism therapeutics.从激素替代疗法到再生支架:当前和新型原发性甲状腺功能减退症治疗方法的综述。
Front Endocrinol (Lausanne). 2022 Oct 5;13:997288. doi: 10.3389/fendo.2022.997288. eCollection 2022.
10
Association of TSHR gene single nucleotide intronic polymorphism with the risk of hypothyroid and hyperthyroid disorders in Yazd province.促甲状腺激素受体基因单核苷酸内含子多态性与亚兹德省甲状腺功能减退和甲状腺功能亢进症发病风险的关联。
Sci Rep. 2022 Sep 21;12(1):15745. doi: 10.1038/s41598-022-19822-0.